PF649 ALPINA: REAL WORLD ANALYSIS OF 1ST LINE RVD TREATMENT IN TRANSPLANT ELIGIBLE AND TRANSPLANT-NON-ELIGIBLE MM PATIENTS WITH A FOCUS ON TOLERABILITY AND EFFICACY

Authors :: H. Einsele
Ella Willenbacher
F. Bauer
S. Sormann
M. Bittrich
Wolfgang Willenbacher
Roman Weger
Source :: HemaSphere. 3:278
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Focus (computing)
medicine.medical_specialty
Tolerability
business.industry
Internal medicine
Medicine
Hematology
Line (text file)
business

Tools